Benzinga’s Top Ratings Upgrades, Downgrades For December 13, 2022
Upgrades For Equinix Inc (NASDAQ:EQIX), Cowen & Co. upgraded the previous rating of Market Perform to Outperform. In…
Annogen Announces Research Project With Pfizer To Test Non-Coding Genetic Sequences
Annogen will functionally annotate tens of thousands of disease-related non-coding sequence variants with the goal of aiding drug discovery
Annogen, the Amsterdam based biotech company behind the SuRE™ technology
Pfizer Expects $10-$15B From mRNA Vaccine Sales By 2030, Sees $17B Revenues Lost Due To Patent Expiry
At Pipeline Day, Pfizer Inc (NYSE: PFE) forecasts annual revenue from its mRNA vaccine portfolio could reach $10-$15 billion by 2030.
Reuters Reported Earlier China’s 111.inc App Starts Retail Sales of Pfizer’s Paxlovid for COVID
https://www.reuters.com/business/healthcare-pharmaceuticals/chinas-111inc-app-starts-retail-sales-pfizers-paxlovid-covid-treatment-2022-12-13/
Pfizer Sees Potential Revenues Of More Than $2B From Respiratory Syncytial Virus Vaccine Candidate, Sees Peak Sales In 2027; Presentation To Begin At 1:00 p.m ET
https://investors.pfizer.com/Investors/Events--Presentations/event-details/2022/Pfizer-Near-Term-Launches--High-Value-Pipeline-Day/default.aspx
Pfizer Near-Term Launches + High-Value Pipeline Day
Start date:
10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Pfizer Declares Q1 2023 Dividend, Raises From $0.40 To $0.41 Per Share
Board of Directors approves increase in quarterly cash dividend to $0.41 per share
Pfizer Inc. (NYSE:PFE) today announced that its board of directors declared an increase in the quarterly cash dividend on the